Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bone Marrow Transplantation|June 15, 2007
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancerL T Vahdat, D J Cohen, D Zipin, et al.Journal of Hematotherapy|February 1, 1997
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell supportK P Papadopoulos, J Ayello, S Tugulea, et al.Bone Marrow Transplantation|August 22, 2002
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancerL T Vahdat, C Balmaceda, K Papadopoulos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamineL Vahdat, K Papadopoulos, D Lange, et al.Bone Marrow Transplantation|July 27, 2005
Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphomaK P Papadopoulos, W Noguera-Irizarry, L Wiebe, et al.Journal of Neuro-Oncology|January 5, 2000
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumorsK P Papadopoulos, C Balmaceda, M Fetell, et al.Bone Marrow Transplantation|November 18, 1998
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adultsK P Papadopoulos, J H Garvin, M Fetell, et al.Pageof 3